Skip to content

Effect of Ayurveda intervention on Cerebral Palsy

An open labelled comparative clinical study to assess the effectiveness of Salavana Upanaha Sweda with and without Parisheka on Spasticity in children with Cerebral palsy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/03/008017
Enrollment
60
Registered
2017-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SPASTIC CEREBRAL PALSY

Interventions

Intervention1: Pariseka and Upanaha: 30 Children of this group will be administered
1] Abyanga with TilaTaila for 15 minutes. 2] DashamoolaKashaya dispensed will be taken in Dharapatra (vessel) and poured continuously, neither too fast nor too slow for about 20-minutes, after complet
Patient of this group will be given with Abyanga from TilaTaila for 15 minutes followed by lukewarm water bath and application of SalavanaUpanaha. Total duration of study is 90 days.

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Children whose parents are willing to sign the informed assent form 2) If participant history of epilepsy,well controlled by medication

Exclusion criteria

Exclusion criteria: 1)Mixed variety of cerebral palsy. 2)Children with infectious diseases like tuberculosis, meningitis 3)Children with poor controlled epilepsy,recurrent status epilepticus, intractable seizures, complex seizures, juvenile diabetes mellitus,severe cognitive impairment. 4) With Severe motor handicap and deformities from long standing spasticity. 5) The children of cerebral palsy with congenital malformations, other systemic illness like congenital heart disease, nephrotic syndrome will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Reduction of spasticity in children with cerebral palsyTimepoint: 90 days

Secondary

MeasureTime frame
Improvement in quality of life and assessment of drug safetyTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Shailaja U

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan, Karnataka

drdrarunraj26@gmail.com9886292826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026